Evidence map›Paper›PMID 24478469›Full record

ArticleJournal of clinical microbiology2014

Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection.

Francisco Toval, Christian-Daniel Köhler, Ulrich Vogel, Florian Wagenlehner, Alexander Mellmann, Angelika Fruth, M Alexander Schmidt, Helge Karch, Martina Bielaszewska, Ulrich Dobrindt

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. A novel phage encoding host defense modulators demonstrates in-vivo therapeutic efficacy against carbapenem-resistant E. coli ST1432.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Emergence of Carbapenem-Resistant UropathogenicPathogens (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Investigating trends in antibiotic resistance ofMicrobiology (Reading, England) · 2024
    Article
  15. Genomic Dissection of an EnteroaggregativeInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Detection and characterization of potentially hybrid enteroaggregative Escherichia coli (EAEC) strains isolated from urinary tract infection.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  18. Article
  19. Multidrug resistance in pathogenicFrontiers in veterinary science · 2024
    Article
  20. Genotypic Characterization of UropathogenicAntibiotics (Basel, Switzerland) · 2023
    Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Francisco TovalInstitute for Hygiene, University of Münster, Münster, Germany.
Christian-Daniel Köhler
Ulrich Vogel
Florian Wagenlehner
Alexander Mellmann
Angelika Fruth
M Alexander Schmidt
Helge Karch
Martina Bielaszewska
Ulrich Dobrindt
University of Münster · DEInstitute of Medical Microbiology and Hygiene · DERobert Koch Institute · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) is the most common cause of community- and hospital-acquired urinary tract infections (UTIs). Isolates from uncomplicated community-acquired UTIs express a variety of virulence traits that promote the efficient colonization of the urinary tract. In contrast, nosocomial UTIs can be caused by E. coli strains that differ in their virulence traits from the community-acquired UTI isolates. UPEC virulence markers are used to distinguish these facultative extraintestinal pathogens, which belong to the intestinal flora of many healthy individuals, from intestinal pathogenic E. coli (IPEC). IPEC is a diarrheagenic pathogen with a characteristic virulence gene set that is absent in UPEC. Here, we characterized 265 isolates from patients with UTIs during inpatient or outpatient treatment at a hospital regarding their phylogenies and IPEC or UPEC virulence traits. Interestingly, 28 of these isolates (10.6%) carried typical IPEC virulence genes that are characteristic of enteroaggregative E. coli (EAEC), Shiga toxin-producing E. coli (STEC), and atypical enteropathogenic E. coli (aEPEC), although IPEC is not considered a uropathogen. Twenty-three isolates harbored the astA gene coding for the EAEC heat-stable enterotoxin 1 (EAST1), and most of them carried virulence genes that are characteristic of UPEC and/or EAEC. Our results indicate that UPEC isolates from hospital patients differ from archetypal community-acquired isolates from uncomplicated UTIs by their spectrum of virulence traits. They represent a diverse group, including EAEC, as well as other IPEC pathotypes, which in addition contain typical UPEC virulence genes. The combination of typical extraintestinal pathogenic E. coli (ExPEC) and IPEC virulence determinants in some isolates demonstrates the marked genome plasticity of E. coli and calls for a reevaluation of the strict pathotype classification of EAEC.

Indexed as

Genetic VariationAdolescentAdultAgedAged, 80 and overChildChild, PreschoolEnteropathogenic Escherichia coliEscherichia coli InfectionsEscherichia coli ProteinsFemaleGenotypeHospitalsHumansInfantInpatientsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID24478469
PMCPMC3911323
OpenAlexW1969209152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.